THE NEED FOR AGGRESSIVE THERAPY OF RHEUMATOID ARTHRITIS

Amor, 1981, Polyarthritis rheumatoid evolvant depuis plus de 10 ans (1966–1978), Ann Med Interne (Paris), 132, 168 Amos RA, Constable TJ, Crookson RA, et al: Rheumatoid arthritis: Relationship of serum C-reactive protein and erythrocyte sedimentation rates and radiographic change. Br Med J 1:195 Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31, 315, 10.1002/art.1780310302 Brook, 1977, Radiographic changes in early rheumatoid arthritis, Ann Rheum Dis, 36, 70, 10.1136/ard.36.1.71 Caruso, 1990, Clinical, laboratory, and radiographic features of early rheumatoid arthritis, J Rheumatol, 17, 1263 Csuka, 1986, Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine, a followup study, JAMA, 255, 10.1001/jama.1986.03370170079039 Dawes, 1986, Rheumatoid arthritis: Treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiologic progression, Br J Rheumatol, 25, 44, 10.1093/rheumatology/25.1.44 Fenner, 1992, Nonsteroidal anti-inflammatory drugs: Benefit/risk evaluation in rheumatic disease, J Rheumatol, 19, 98 Fries, 1990, Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis, Arthritis Rheum, 33, 1611, 10.1002/art.1780331102 Fries, 1990, A toxicity index for comparison of side effects among different drugs, Arthritis Rheum, 31, 121, 10.1002/art.1780330117 Fuchs, 1989, Evidence of significant radiologic erosions in rheumatoid arthritis within the first 2 years of disease, J Rheumatol, 16, 585 Gabriel, 1990, NSAID induced ulcers, an emerging epidemic?, J Rheumatol, 17, 1 Gabriel, 1988, Rheumatoid arthritis: Can the long-term outcome be altered?, Mayo Clin Proc, 63, 58, 10.1016/S0025-6196(12)62665-2 Harris, 1990, Rheumatoid arthritis—pathophysiology and implications for therapy, N Engl J Med, 322, 1277, 10.1056/NEJM199005033221805 Healey, 1991, Aggressive therapy of early rheumatoid arthritis: A new approach, Virginia Mason Clinic Bulletin, 45, 43 Hepburn, 1986, What is a disease modifying antirheumatic drug?, J Rheumatol, 15, 40 Huskisson, 1987, Combination chemotherapy in rheumatoid arthritis [editorial], Br J Rheumatol, 26, 243, 10.1093/rheumatology/26.4.243 Inannuzzi, 1983, Does drug therapy slow radiographic deterioration in rheumatoid arthritis?, N Engl J Med, 309, 1023, 10.1056/NEJM198310273091704 1959, A comparison of prednisolone and aspirin and other analgesics in the treatment of rheumatoid arthritis, Ann Rheum Dis, 18, 178 Klippel, 1988, New therapies for the rheumatic diseases, Bull Rheum Dis, 38, 1 Kushner, 1989, Does aggressive therapy of rheumatoid arthritis affect outcome?, J Rheumatol, 16, 1 Markinson, 1991, Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis, Semin Arthritis Rheum, 21, 4, 10.1016/0049-0172(91)90046-3 McCarty, 1972, Treatment of rheumatoid joint inflammation with triamcinolone hexacetonide, Arthritis Rheum, 15, 157, 10.1002/art.1780150205 McCarty, 1982, Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine, JAMA, 248, 1718, 10.1001/jama.1982.03330140028027 McKenna, 1988, Clinical and laboratory assessments of outcome in rheumatoid arthritis, Br J Rheumatol, 27, 12 Panush, 1992, Assessment and prognosis of rheumatoid arthritis, Current Opinions in Rheumatology, 4, 355, 10.1097/00002281-199206000-00013 Paulus, 1988, Antimalarial agents compared with or in combination with other disease-modifying antirheumatic drugs, Am J Med, 85, 45, 10.1016/0002-9343(88)90362-2 Paulus, 1990, Current controversies in rheumatology: The use of drug-modifying antirheumatic agents in rheumatoid arthritis, Arthritis Rheum, 33, 113, 10.1002/art.1780330116 Pincus, 1958, Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term trials, J Clin Epidemiol, 41, 1037, 10.1016/0895-4356(88)90072-8 Pincus, 1992, The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritis, Semin Arthritis Rheum, 21, 2, 10.1016/0049-0172(92)90008-2 Pincus, 1986, Taking mortality in rheumatoid arthritis seriously—predictive markers, socioeconomic status, and comorbidity [editorial], J Rheumatol, 13, 1941 Pincus, 1989, Re-assessment of twelve traditional paradigms concerning the diagnosis, prevalence, morbidity and mortality of rheumatoid arthritis, Scand J Rheumatol, 79, 67, 10.3109/03009748909092614 Pincus, 1991, Treatment of rheumatoid arthritis: Challenges in traditional paradigms [editorial], Ann Intern Med, 115, 825, 10.7326/0003-4819-115-10-825 Ropes, 1958, 1958 Revision of diagnostic criteria for rheumatoid arthritis, Bull Rheum Dis, 9, 175 Roth, 1989, Rethinking rheumatic disease therapy [editorial], J Rheumatol, 16, 140 Roubenoff, 1987, Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m-AMSA, Arthritis Rheum, 30, 1187, 10.1002/art.1780301017 Scott, 1985, Methods of x-ray assessment in rheumatoid arthritis: A re-evaluation, Br J Rheumatol, 24, 349, 10.1093/rheumatology/24.1.31 Scott, 1987, Long-term outcome of treating rheumatoid arthritis: Results after 20 years, Lancet, 1, 1108, 10.1016/S0140-6736(87)91672-2 Sharp, 1989, Radiographic assessment as an outcome measure in rheumatoid arthritis, Arthritis Rheum, 32, 221, 10.1002/anr.1780320218 Sherrer, 1986, The development of disability in rheumatoid arthritis, Arthritis Rheum, 29, 494, 10.1002/art.1780290406 Sigler, 1974, Gold salts in the treatment of rheumatoid arthritis, a double-blind study, Ann Intern Med, 80, 21, 10.7326/0003-4819-80-1-21 Siturayake, 1987, Long-term treatment of rheumatoid arthritis with sulfasalazine, gold, or penicillamine. A comparison using life-table methods, Ann Rheum Dis, 46, 1977 Stillman, 1990, Nonsteroidal anti-inflammatory drug nephrotoxicity, Arch Intern Med, 150, 268, 10.1001/archinte.1990.00390140024006 Thompson, 1985, Practical results of treatment with disease-modifying antirheumatic drugs, Br J Rheumatol, 24, 167, 10.1093/rheumatology/24.2.167 Thould, 1965, Assessment of radiologic changes in the hands and feet in rheumatoid arthritis, Ann Rheum Dis, 25, 220, 10.1136/ard.25.3.220 Tiliakos, 1986, Low dose cytotoxic drug combination therapy in intractable rheumatoid arthritis: Two years later [abstract 6—51], Arthritis Rheum, 29 Weisman, 1989, Natural history and treatment decisions in rheumatoid arthritis revisited, Arthritis Care and Research, 2, 575, 10.1002/anr.1790020318 Wilke, 1991, Therapy for rheumatoid arthritis: Combinations of disease-modifying drugs and new paradigms, Semin Arthritis Rheum, 21, 21, 10.1016/0049-0172(91)90048-5 Wilke, 1989, Combination chemotherapy for severe rheumatoid arthritis, IM—Internal Medicine for the Specialist, 10, 59 Wilkens, 1987, Immunomodulation is often used too late, 367 Wilkens, 1991, Prognostic staging for therapy of rheumatoid arthritis, Semin Arthritis Rheum, 21, 40, 10.1016/0049-0172(91)90050-A Wilske, 1989, Remodeling the pyramid—a concept whose time has come [editorial], J Rheumatol, 16, 565 Wolfe, 1985, Remission in rheumatoid arthritis, J Rheumatol, 12, 245 Wright, 1983, Questions and clinical trials [editorial], BMJ, 287, 569, 10.1136/bmj.287.6392.569 Yocum, 1992, Cyclosporine in rheumatoid arthritis: Beyond expectation, Semin Arthritis Rheum, 21, 39, 10.1016/0049-0172(92)90012-3 Young, 1980, The clinical assessment of joint inflammatory activity in rheumatoid arthritis related to radiographic progression, Rheumatology Rehabilitation, 19, 14, 10.1093/rheumatology/19.1.14